Anti-epidermal growth factor receptor monoclonal antibody combined with chemotherapy in penile cancer: A prospective, multicenter, phase 1 study.

Penile cancer is a rare malignancy, and treatment options for advanced stages are limited, often yielding unsatisfactory outcomes. This prospective, multicenter, phase 1 clinical study was conducted to evaluate the preliminary safety, tolerability, a…

Preview only. Read the full abstract at the source